AMRITPAL KAUR: Open Payments
NPI 1407496060 · TRENTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,099 in 50 payments from 12 companies in 2025. Trend: 2023 $1,056 · 2024 $1,022 · 2025 $1,099
Food & beverage: $1,099
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $352 |
| Phathom Pharmaceuticals, Inc. | 3 | $160 |
| Novo Nordisk Inc | 10 | $159 |
| ABBVIE INC. | 5 | $87 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| PFIZER INC. | 4 | $71 |
| Lilly USA, LLC | 3 | $54 |
| Exact Sciences Corporation | 3 | $50 |
| Amgen Inc. | 2 | $32 |
| SANOFI PASTEUR INC. | 1 | $23 |
Products named: Kerendia, VOQUEZNA, UBRELVY, FASENRA, Rybelsus, MOUNJARO, Cologuard Collection Kit, ELIQUIS.
Industry payments across NJ — which companies pay providers there.
